Interactions of clinical relevance associated with concurrent administration of prescription drug and food or medicinal plants: a systematic review protocol

被引:9
|
作者
Orellana-Paucar, Adriana [1 ]
Vintimilla-Rojas, Daniela [1 ]
机构
[1] Univ Cuenca, Carrera Nutr & Dietet, Fac Ciencias Med, Cuenca, Ecuador
关键词
Concurrent administration; Pharmacological interaction; Food-drug interaction; herb-drug interaction; Safety; Human; HERBAL SUPPLEMENTS; DIETARY; IMPACT; MECHANISMS;
D O I
10.1186/s13643-019-1259-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background An inadequate combination of prescription drugs with food or medicinal plants could cause adverse effects in patients or produce negative therapeutic results. Therefore, this generic systematic review protocol aims to identify and synthesize the literature on clinical characteristics and safety issues of these types of pharmacological interactions occurring in children, adolescents, adults, pregnant/lactating women, and older adults. Methods/design This generic protocol follows the stated guidelines from the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement. A literature search will be performed in PubMed, Scopus, and Virtual Health Library (VHL) electronic databases from 1960 till present for studies reporting clinical characteristics and safety issues associated with pharmacological interactions occurring between prescription drugs and food or medicinal plants in participants from birth-age to >= 65-year-old, including pregnant/lactating women. Lateral searching will be carried out in PubMed via related citation. Two reviewers will carry out an independent evaluation of eligible studies as well as the corresponding data extraction of the selected ones. Subsequently, the methodological quality evaluation of the selected articles will be completed using the corresponding Joanna Briggs Institute Checklists. Moreover, the quality of evidence will be graded according to the criteria of the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Working Group. Quantitative research in humans comprising clinical trials and clinical, comparative and, observational studies will be included. The main outcomes of this protocol involve reported potential food-drug and herb-drug interactions, associated safety issues, and adverse reactions along with the generic name of the prescribed drug and the scientific name of the food and medicinal plants involved in these types of pharmacological interactions. Finally, findings extracted from the selected studies will be summarized in a narrative synthesis. Discussion This generic systematic review protocol seeks to synthesize and critically evaluate current knowledge besides to identify any comprehension gaps in the concurrent administration of prescription drugs with food and herbs. By achieving a better understanding of this topic, this information will allow healthcare professionals to develop useful strategies to recognize, manage, and prevent these types of pharmacological interactions at different age stages, including pregnant/lactating women. Systematic review registration PROSPERO CRD42018117308
引用
收藏
页数:6
相关论文
共 50 条
  • [41] The Role of the US Food and Drug Administration Review Process: Clinical Trial Endpoints in Oncology
    McKee, Amy E.
    Farrell, Ann T.
    Pazdur, Richard
    Woodcock, Janet
    ONCOLOGIST, 2010, 15 : 13 - 18
  • [42] US Food and Drug Administration Systematic Review of Pregnancy Registries: Follow-up Analysis
    Sahin, L.
    Hammad, H.
    Bird, S.
    Gelperin, K.
    Hampp, C.
    Leishear, K.
    Taylor, L.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2015, 103 (05) : 391 - 391
  • [43] A systematic review of adverse drug events associated with administration of common asthma medications in children
    Leung, James S.
    Johnson, David W.
    Sperou, Arissa J.
    Crotts, Jennifer
    Saude, Erik
    Hartling, Lisa
    Stang, Antonia
    PLOS ONE, 2017, 12 (08):
  • [44] Device Safety Implications of the Clinical Data Leading to US Food and Drug Administration Approval of Soft-Tissue Fillers A Systematic Review
    Lohman, Mary E.
    Ghobadi, Comeron W.
    Xu, Shuai
    JAMA FACIAL PLASTIC SURGERY, 2017, 19 (05) : 421 - 429
  • [45] Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis
    Dechanont, Supinya
    Maphanta, Sirada
    Butthum, Bodin
    Kongkaew, Chuenjid
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (05) : 489 - 497
  • [46] Herb-drug interactions between the medicinal mushrooms Lingzhi and Yunzhi and cytotoxic anticancer drugs: a systematic review
    Lam, Chun Sing
    Cheng, Lok Pui
    Zhou, Li Min
    Cheung, Yin Ting
    Zuo, Zhong
    CHINESE MEDICINE, 2020, 15 (01)
  • [47] Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: A systematic review
    Candeloro, Matteo
    Carlin, Stephanie
    Shapiro, Michelle J.
    Douketis, James D.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (03)
  • [48] Considerations for Clinical Review of Cellular Therapy Products: Perspectives of the China Food and Drug Administration Center for Drug Evaluation
    Liu, Yantong
    Zhao, Chenyang
    Gao, Liucun
    Yang, Huan
    He, Ruyi
    Gao, Chenyan
    HUMAN GENE THERAPY, 2018, 29 (02) : 121 - 127
  • [49] Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2017
    Yu, Jingjing
    Petrie, Ichiko D.
    Levy, Rene H.
    Ragueneau-Majlessi, Isabelle
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (02) : 135 - 144
  • [50] Adverse Events Associated with Intranasal Sprays: An Analysis of the Food and Drug Administration Database and Literature Review
    Ahsanuddin, Salma
    Povolotskiy, Roman
    Tayyab, Rahma
    Nasser, Wissam
    Barinsky, Gregory L.
    Grube, Jordon G.
    Paskhover, Boris
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2021, 130 (11): : 1292 - 1301